A.MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
Name and address of the manufacturers responsible for batch release
Teva Pharmaceutical Works Private Limited Company
Pallagi út 13
TEVA Pharmaceutical Works Private Limited Company
Táncsics Mihály út 82
Hungary (Headquarters: 4042 Debrecen, Pallagi út 13)
TEVA UK Ltd
Eastbourne, East Sussex, BN22 9AG
2031 GA Haarlem
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.
B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
- Telmisartan teva - C09CA07
- Pritor - C09CA07
- Micardis - C09CA07
- Tolura - C09CA07
- Kinzalmono (telmisartan boehringer ingelheim pharma kg) - C09CA07
Prescription drugs listed. ATC Code: "C09CA07"
Medicinal product subject to medical prescription.
C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Periodic Safety Update Reports
The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines
D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Risk Management Plan (RMP)